来自骨髓细胞的抑制细胞和肺高血压
Hui Zhang1,2,3,4,5, Qi-Wei Li1,3,4,5,6, Yuan-Yuan Li1,3,4,5
1Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu, China.
Frontiers in immunology
|June 23, 2023
概括
骨髓衍生抑制细胞 (MDSCs) 在肺高血压 (PH) 的发展中起着关键作用. 针对MDSC提供了一种新的治疗策略,用于治疗严重PH,一种类似癌症的疾病.
科学领域:
- 免疫学 免疫学 免疫学
- 肺部病理学 肺部病理学
- 血管生物学 血管生物学
背景情况:
- 肺高血压 (PH) 是一种慢性疾病,导致肺血管阻力和压力增加.
- 驱动PH的精确分子机制仍然不完全理解.
- 一个改变的免疫微环境,涉及各种细胞和分子,越来越多地涉及PH的发病.
研究的目的:
- 审查骨髓衍生抑制细胞 (MDSC) 和肺高血压 (PH) 之间的复杂关系.
- 探索免疫细胞,细胞因子,化学因子和代谢在MDSC介导的PH中的作用.
- 在MDSC中确定PH治疗的潜在治疗点,特别是严重的形式.
主要方法:
- 文献综述侧重于髓质衍生抑制细胞 (MDSC) 和肺高血压 (PH).
- 分析MDSCs,免疫细胞,信号分子和PH中的代谢途径之间的相互作用.
- 检查MDSCs作为严重PH的潜在治疗点.
主要成果:
- 骨髓衍生抑制细胞 (MDSCs) 参与PH的发展和进展.
- MDSCs表现出强大的免疫抑制功能,可能会加剧PH.
- 严重的PH与癌症具有共同的特征,其中MDSC已知起着重要作用.
结论:
- MDSC与肺高血压 (PH) 的发展和预后密切相关.
- 针对MDSCs为PH提供了一个有前途的新型治疗策略,特别是严重的病例.
- 对MDSC特定目标的进一步研究可能会彻底改变PH治疗.
相关概念视频
Pulmonary Hypertension: Classification and Pathogenesis
234
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
234
Differentiation of Common Myeloid Progenitor Cells
3.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
212
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
212
Multipotency of Hematopoietic Stem Cells
3.2K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.2K


